Boxing-Turkey's Erdemir gets two-year ban for doping violation
Nov 22 (Reuters) -Turkish light middleweight boxer Tugrulhan Erdemir has been banned for two years by the Court of Arbitration for Sport (CAS) for breaching anti-doping rules, the International Testing Agency (ITA) said on Friday.
CAS had confirmed in July Erdemir's provisional suspension, which had ruled him out of the 71kg event at the Paris Olympics and a second hearing took place in October when the court found he had broken anti-doping rules.
"Erdemir returned an Atypical Finding (ATF) for the prohibited substance hydrochlorothiazide," the ITA said in a statement. "Hydrochlorothiazide is prohibited under the 2024 WADA Prohibited list as a diuretic and masking agent (S.5)."
Masking agents can hide the presence of banned substances, making them harder to detect in tests. The diuretic can flush out other banned substances and conceal drug use without enhancing performance directly.
The 25-year-old, who failed a doping test on Feb. 17, will have results obtained starting from that date disqualified. Erdemir won a bronze medal in the light middleweight category at last year's European Games in Poland.
Reporting by Shifa Jahan in Bengaluru
Editing by Toby Davis
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
